HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
S J Shin Selected Research
S J Shin Research Topics
Disease
9
Neoplasms (Cancer)
01/2023 - 09/2000
8
Type 2 Diabetes Mellitus (MODY)
08/2015 - 07/2000
6
Diabetic Nephropathies (Diabetic Nephropathy)
11/2013 - 04/2000
4
Lung Diseases (Lung Disease)
01/2017 - 02/2013
3
Carcinoma (Carcinomatosis)
01/2023 - 11/2000
3
Infections
01/2017 - 05/2000
3
Inflammation (Inflammations)
12/2016 - 06/2010
3
Hyperglycemia
12/2002 - 04/2000
2
Disease Progression
01/2023 - 01/2023
2
Melanoma (Melanoma, Malignant)
01/2017 - 02/2000
2
Lymphoma (Lymphomas)
01/2013 - 12/2000
2
Tuberculosis (Tuberculoses)
04/2012 - 11/2009
2
Proteinuria
03/2010 - 07/2008
2
Stomach Neoplasms (Stomach Cancer)
06/2008 - 08/2007
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2023
1
Pseudomonas Infections
01/2017
1
Hypersensitivity (Allergy)
01/2016
1
Immediate Hypersensitivity
01/2016
1
Mucormycosis
12/2015
1
Atherosclerosis
08/2015
1
Carotid Stenosis (Carotid Artery Stenosis)
08/2015
1
Carotid Artery Diseases
08/2015
1
Albuminuria
01/2013
1
Neoplasm Metastasis (Metastasis)
01/2012
1
Legg-Calve-Perthes Disease (Perthes Disease)
10/2009
1
Myasthenia Gravis
07/2008
1
Ductal Carcinoma
07/2008
1
Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
07/2008
1
Breast Neoplasms (Breast Cancer)
07/2008
Drug/Important Bio-Agent (IBA)
4
Glucose (Dextrose)
FDA Link
Generic
11/2013 - 07/2000
4
Proteins (Proteins, Gene)
FDA Link
01/2013 - 06/2001
3
Albumins
IBA
08/2015 - 06/2001
3
Insulin (Novolin)
FDA Link
09/2001 - 04/2000
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2023 - 01/2017
2
Immune Checkpoint Inhibitors
IBA
01/2023 - 10/2022
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2016 - 06/2008
2
Creatinine
IBA
08/2015 - 03/2010
2
Phenobarbital (Luminal)
FDA Link
08/2015 - 01/2001
2
Cytokines
IBA
04/2014 - 08/2004
2
Anti-Bacterial Agents (Antibiotics)
IBA
04/2014 - 02/2013
2
Antigens
IBA
11/2009 - 05/2000
2
Codon (Codons)
IBA
09/2001 - 04/2001
1
cobimetinib
IBA
01/2023
1
human ERBB2 protein
IBA
01/2023
1
Programmed Cell Death 1 Receptor
IBA
01/2023
1
Trastuzumab (Herceptin)
FDA Link
01/2023
1
B7-H1 Antigen
IBA
01/2023
1
Biosimilar Pharmaceuticals
IBA
01/2023
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2023
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2023
1
atezolizumab
IBA
01/2023
1
NVP-BKM120
IBA
01/2017
1
NADPH Oxidases (NAD(P)H oxidase)
IBA
01/2017
1
Inflammasomes
IBA
01/2017
1
Amikacin (A.M.K)
FDA Link
Generic
01/2017
1
ribociclib
IBA
01/2017
1
trametinib
IBA
01/2017
1
Calcitriol Receptors (Calcitriol Receptor)
IBA
12/2016
1
25-hydroxyvitamin D
IBA
12/2016
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2016
1
Cathelicidins
IBA
12/2016
1
hydroxide ion
IBA
12/2016
1
calcium silicate (Wollastonite)
IBA
12/2016
1
25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)
IBA
12/2016
1
Vitamin D-Binding Protein
IBA
12/2016
1
Vitamin D
FDA Link
Generic
12/2016
1
Antimicrobial Peptides
IBA
12/2016
1
Defensins
IBA
12/2016
1
Platinum
IBA
01/2016
1
Immunosuppressive Agents (Immunosuppressants)
IBA
12/2015
1
liposomal amphotericin B
FDA Link
12/2015
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
10/2014
1
HDL Cholesterol
IBA
10/2014
1
Interleukin-23 (Interleukin 23)
IBA
04/2014
1
Interleukin-17 (Interleukin 17)
IBA
04/2014
1
Ferritins (Ferritin)
IBA
11/2013
1
Phosphotransferases (Kinase)
IBA
01/2013
1
Superoxide Dismutase
IBA
01/2013
1
Resveratrol
IBA
01/2013
1
Quinolones
IBA
04/2012
1
Adenosine Triphosphate (ATP)
IBA
01/2012
1
Ubiquitin
IBA
06/2010
1
NF-kappa B (NF-kB)
IBA
06/2010
1
AG 85
IBA
11/2009
1
Tacrolimus (Prograf)
FDA Link
Generic
07/2008
1
Cadherins (E-Cadherin)
IBA
07/2008
1
Leucovorin (Folinic Acid)
FDA Link
06/2008
1
Fluorouracil (Carac)
FDA Link
Generic
06/2008
1
Paraffin
IBA
05/2007
Therapy/Procedure
3
Therapeutics
10/2022 - 01/2013
3
Drug Therapy (Chemotherapy)
01/2016 - 08/2007
3
Combination Drug Therapy (Combination Chemotherapy)
06/2008 - 12/2000
2
Stents
09/2001 - 01/2000
1
Intravenous Infusions
01/2023
1
Immunotherapy
10/2022
1
Skin Care
01/2013
1
Neoadjuvant Therapy
01/2012
1
Glycemic Control
06/2010
1
Acetabuloplasty
10/2009
1
Salvage Therapy
06/2008